- Report
- January 2025
- 150 Pages
Global
From €4468EUR$4,995USD£3,868GBP
- Report
- May 2024
- 224 Pages
Global
From €4468EUR$4,995USD£3,868GBP
- Report
- March 2024
- 131 Pages
Global
€4468EUR$4,995USD£3,868GBP
- Report
- January 2025
- 144 Pages
Global
From €2650EUR$2,963USD£2,294GBP
€3533EUR$3,950USD£3,059GBP
- Report
- December 2023
- 143 Pages
Global
From €2986EUR$3,338USD£2,585GBP
€3981EUR$4,450USD£3,446GBP
- Report
- April 2020
- 115 Pages
Global
From €2456EUR$2,745USD£2,126GBP
€3274EUR$3,660USD£2,834GBP
- Report
- December 2024
- 150 Pages
Global
From €3003EUR$3,358USD£2,600GBP
€3533EUR$3,950USD£3,059GBP
- Report
- November 2023
- 245 Pages
Global
From €3981EUR$4,450USD£3,446GBP
- Report
- November 2023
- 420 Pages
Global
From €3981EUR$4,450USD£3,446GBP
- Report
- December 2021
- 191 Pages
Global
From €3981EUR$4,450USD£3,446GBP
- Report
- January 2026
- 150 Pages
Japan
From €4339EUR$4,850USD£3,756GBP
- Report
- January 2026
- 150 Pages
India
From €4339EUR$4,850USD£3,756GBP
- Report
- October 2025
- 150 Pages
Germany
From €4339EUR$4,850USD£3,756GBP
- Report
- September 2025
- 150 Pages
China
From €4339EUR$4,850USD£3,756GBP
- Report
- September 2025
- 150 Pages
Canada
From €4339EUR$4,850USD£3,756GBP
- Report
- March 2025
- 150 Pages
Global
From €4339EUR$4,850USD£3,756GBP
- Report
- February 2025
- 150 Pages
Global
From €4339EUR$4,850USD£3,756GBP
- Report
- January 2024
- 150 Pages
Global
From €4339EUR$4,850USD£3,756GBP
- Report
- November 2023
- 150 Pages
Global
From €4339EUR$4,850USD£3,756GBP
- Report
- January 2025
- 111 Pages
Global
From €3500EUR$4,191USD£3,136GBP

The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders.
The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more